Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; What is complementary and alternative medicine, and can it be used safely? -- Types of complementary and alternative therapies -- Herbs, vitamins, and supplements -- Symptom management with complementary and alternative medicine -- CAM therapy use by site -- Healthy living.
Building capacity for cancer treatment in low-income countries with particular reference to East Africa by Ian Magrath and Simon Sutcliffe.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Contents:; The Current Cancer Care Landscape: An Imperative for Change -- Patient-Centered Communication and Shared Decision Making -- The Workforce Caring for Patients with Cancer -- The Evidence Base for High-Quality Cancer Care -- A Learning Health Care Information Technology System for Cancer -…
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, May 30, 2024 | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, May 30, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; 1. HISTORY OF IMMUNOTHERAPY -- 2. PRINCIPLES OF IMMUNOLOGY AND IMMUNOTHERAPY -- 3. CYTOKINES IN IMMUNOTHERAPY -- 4. IMMUNE CHECKPOINT INHIBITORS -- 5. BACILLUS CALMETTE-GUÉRIN - 6. ORAL IMMUNOMODULATORY AGENTS --7. ACTIVE IMMUNITY: VACCINE THERAPY -- 8. PASSIVE/ADOPTIVE IMMUNOTH…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available |
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |